Compound Detail
CHEMBL5594307
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5594307 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CUZAKSQNTHNHNZ-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
400.5
MW (Da)
3.54
ALogP
6
HBA
1
HBD
97.7
PSA (Ų)
0.76
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.59
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HeLa CHEMBL399 | IC50 | 5.59 | 5.59 | 2560.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HeLa | IC50 | = | 2560.0 | nM | 5.59 | Antiproliferative activity against human HeLa cells assessed as reduction in cel... | 38959729 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38959729 | 10.1016/j.ejmech.2024.116617 | HeLa | 1 |
Data from ChEMBL 36 via Core Engine